We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » COMBO PRODUCT FEES COULD BE LOWERED, FDA SAYS
COMBO PRODUCT FEES COULD BE LOWERED, FDA SAYS
October 1, 2004
Manufacturers of pharmaceuticals or devices that seek FDA approval for a combination product may be eligible to reduce or waive agency user fees when they submit more than one application, according to a draft guidance from the agency.